The infectious complications are associated with certain blood products of human origin used in the treatment of von Willebrand disease. In the past, viral transmission (HIV, hepatitis B and C) was a major complication of therapy for this disease. However, since the introduction of effective viral inactivation procedures at the end of the 1980s, such risk has been reduced enormously.